pilsicainide has been researched along with Anterior Fascicular Block in 15 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Excerpt | Relevance | Reference |
---|---|---|
"Population pharmacokinetics (PK) of a sodium channel-blocking antiarrhythmic, pilsicainide, was studied using the nonlinear mixed-effects modeling technique in 91 patients with cardiac arrhythmias (80 suspected Brugada syndrome [BrS] and 11 with atrial fibrillation) who received an intravenous infusion of 10 mg of the drug." | 9.12 | Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias. ( Echizen, H; Kishi, R; Kobayashi, S; Masuhara, K; Matsumoto, N; Mihara, K; Miyake, F; Nakazawa, K; Ogawa, R; Takagi, A; Takahashi, H, 2006) |
"Population pharmacokinetics (PK) of a sodium channel-blocking antiarrhythmic, pilsicainide, was studied using the nonlinear mixed-effects modeling technique in 91 patients with cardiac arrhythmias (80 suspected Brugada syndrome [BrS] and 11 with atrial fibrillation) who received an intravenous infusion of 10 mg of the drug." | 5.12 | Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias. ( Echizen, H; Kishi, R; Kobayashi, S; Masuhara, K; Matsumoto, N; Mihara, K; Miyake, F; Nakazawa, K; Ogawa, R; Takagi, A; Takahashi, H, 2006) |
"We administered pilsicainide chloride, a class Ic pure sodium channel blocker, to patients with Brugada syndrome (BS) and evaluated the occurrence of ventricular arrhythmia (VA) and T-wave alternans (TWA)." | 3.72 | Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. ( Banba, K; Emori, T; Hina, K; Kita, T; Kusano, KF; Matsubara, H; Morita, H; Morita, ST; Nagase, S; Nakamura, K; Nishii, N; Ohe, T; Tani, Y; Watanabe, A, 2003) |
" This case report describes a patient in whom a typical Brugada ECG pattern developed during fever and could be reproduced at normal body temperature by administration of pilsicainide." | 3.72 | Brugada-like electrocardiographic pattern unmasked by fever. ( Kanmatsuse, K; Kofune, T; Masaki, R; Okubo, K; Okumura, Y; Oshikawa, N; Ozawa, Y; Saito, S; Sugimura, H; Takagi, Y; Wakita, R; Watanabe, I; Yamada, T, 2004) |
" During hospitalization, atrial fibrillation developed, and oral pilsicainide was administered." | 3.71 | Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. ( Aizawa, Y; Chinushi, M; Chinushi, Y; Toida, T, 2002) |
"Amiodarone (200 mg/day) was administered for 6 months and programmed ventricular stimulation was repeated." | 1.32 | Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. ( Kanmatsuse, K; Kasamaki, Y; Kofune, T; Masaki, R; Ohkubo, K; Okumura, Y; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, I; Yamada, T, 2003) |
"Ventricular fibrillation was induced with double extrastimuli applied to the right ventricular outflow tract." | 1.31 | [Brugada syndrome occurring in an identical twin: a case report]. ( Fujiki, A; Inoue, H; Mizumaki, K; Nishida, K; Sakabe, M; Sugao, M; Tsuneda, T, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (86.67) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Omichi, C | 1 |
Fujimoto, N | 1 |
Kawasaki, A | 1 |
Kasai, A | 1 |
Ohkubo, K | 2 |
Watanabe, I | 3 |
Okumura, Y | 3 |
Ashino, S | 1 |
Kofune, M | 1 |
Nagashima, K | 1 |
Nakai, T | 1 |
Kunimoto, S | 1 |
Kasamaki, Y | 2 |
Hirayama, A | 1 |
Takagi, M | 1 |
Doi, A | 1 |
Takeuchi, K | 1 |
Yoshikawa, J | 1 |
Sakabe, M | 1 |
Fujiki, A | 1 |
Tsuneda, T | 1 |
Nishida, K | 1 |
Sugao, M | 1 |
Mizumaki, K | 1 |
Inoue, H | 1 |
Morita, H | 3 |
Takenaka-Morita, S | 1 |
Fukushima-Kusano, K | 1 |
Kobayashi, M | 1 |
Nagase, S | 3 |
Kakishita, M | 1 |
Nakamura, K | 3 |
Emori, T | 3 |
Matsubara, H | 3 |
Ohe, T | 3 |
Nogami, A | 1 |
Nakao, M | 1 |
Kubota, S | 1 |
Sugiyasu, A | 1 |
Doi, H | 1 |
Yokoyama, K | 1 |
Yumoto, K | 1 |
Tamaki, T | 1 |
Kato, K | 1 |
Hosokawa, N | 1 |
Sagai, H | 1 |
Nakamura, H | 1 |
Nitta, J | 1 |
Yamauchi, Y | 1 |
Aonuma, K | 1 |
Yamada, T | 2 |
Masaki, R | 2 |
Kofune, T | 2 |
Oshikawa, N | 2 |
Saito, S | 2 |
Ozawa, Y | 2 |
Kanmatsuse, K | 2 |
Furuhashi, M | 1 |
Uno, K | 1 |
Satoh, S | 1 |
Hoshikawa, K | 1 |
Sakai, E | 1 |
Tsuchihashi, K | 1 |
Shimamoto, K | 1 |
Morita, ST | 1 |
Banba, K | 1 |
Nishii, N | 1 |
Tani, Y | 1 |
Watanabe, A | 1 |
Kusano, KF | 2 |
Hina, K | 1 |
Kita, T | 1 |
Wakita, R | 1 |
Takagi, Y | 1 |
Okubo, K | 1 |
Sugimura, H | 1 |
Ogawa, R | 1 |
Kishi, R | 1 |
Mihara, K | 1 |
Takahashi, H | 1 |
Takagi, A | 1 |
Matsumoto, N | 1 |
Masuhara, K | 1 |
Nakazawa, K | 1 |
Miyake, F | 1 |
Kobayashi, S | 1 |
Echizen, H | 1 |
Takenaka, S | 1 |
Hisamatsu, K | 1 |
Shimizu, W | 1 |
Aiba, T | 1 |
Kurita, T | 1 |
Kamakura, S | 1 |
Chinushi, Y | 1 |
Chinushi, M | 1 |
Toida, T | 1 |
Aizawa, Y | 1 |
Sahara, M | 1 |
Sagara, K | 1 |
Yamashita, T | 1 |
Abe, T | 1 |
Kirigaya, H | 1 |
Nakada, M | 1 |
Iinuma, H | 1 |
Fu, LT | 1 |
Watanabe, H | 1 |
1 trial available for pilsicainide and Anterior Fascicular Block
Article | Year |
---|---|
Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Block; | 2006 |
14 other studies available for pilsicainide and Anterior Fascicular Block
Article | Year |
---|---|
Ischemia-induced Brugada-type ST-segment alternans and Brugada syndrome.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Brugada Syndrome; Bundle-Branch Block; Coronary Artery | 2010 |
A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Diagnosis, Differential; Elect | 2011 |
Pilsicanide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Humans; Lidocaine; Long QT | 2002 |
[Brugada syndrome occurring in an identical twin: a case report].
Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Diseases in Twins; Electrocardiography; Humans; Lidocai | 2002 |
Risk stratification for asymptomatic patients with Brugada syndrome.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrocardiog | 2003 |
Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Glucose; Heart Arrest; Huma | 2003 |
Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrocardiogr | 2003 |
Right bundle branch block and coved-type ST-segment elevation mimicked by acute cholecystitis.
Topics: Aged; Bundle-Branch Block; Cholecystitis, Acute; Diagnosis, Differential; Electrocardiography; Femal | 2003 |
Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle-Branch Block; Electrocardiography; Femal | 2003 |
Brugada-like electrocardiographic pattern unmasked by fever.
Topics: Adult; Body Temperature; Bundle-Branch Block; Electrocardiography; Fever; Humans; Lidocaine; Male; S | 2004 |
Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Ele | 2001 |
Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation.
Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiotonic Agents; Electrocardiography; Heart Ventricl | 2001 |
Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina.
Topics: Acetylcholine; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2002 |
J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome?
Topics: Adult; Bundle-Branch Block; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Male; S | 2002 |